Stampidine

Drug Profile

Stampidine

Alternative Names: HI-113; PHI-113

Latest Information Update: 27 Sep 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Parker Hughes Institute
  • Developer Paradigm Pharmaceuticals; Parker Hughes Institute
  • Class Antiretrovirals
  • Mechanism of Action RNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Adenovirus infections; HIV-1 infections

Most Recent Events

  • 16 Feb 2006 This compound appears to still be in active development
  • 16 Oct 2003 A preclinical study has been added to the Viral Infections pharmacodynamics section
  • 20 Nov 2002 Two studies have been added to the Viral infections antimicrobial activities section and one study has been added to the adverse events and pharmacokinetics sections ,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top